Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petros Kechagioglou

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 7, 2019
Multiwalled Carbon Nanotubes for Dental ApplicationsPetros Kechagioglou, Eleftherios Andriotis, Petros Papagerakis, et al.
Frontiers in Cell and Developmental Biology|August 8, 2022
Recent advances in targeting protein kinases and pseudokinases in cancer biologyKristina Riegel, Parthiban Vijayarangakannan, Petros Kechagioglou, et al.
Anticancer Research|March 6, 2014
Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expressionPetros Kechagioglou, Rigini M Papi, Xeni Provatopoulou, et al.
Chemical Biology & Drug Design|March 3, 2016
The Synthesis of 1,3,5-triazine Derivatives and JNJ7777120 Analogues with Histamine H4 Receptor Affinity and Their Interaction with PTEN PromoterGniewomir Latacz, Petros Kechagioglou, Rigini Papi, et al.
Iscience|June 30, 2025
CETSA-MS unveils novel targets engaged by rigosertib to promote anti-tumor activity and inflammatory responsesPetros Kechagioglou, Hajime Yurugi, Camille Dupont, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|March 7, 2019
Multiwalled Carbon Nanotubes for Dental ApplicationsPetros Kechagioglou, Eleftherios Andriotis, Petros Papagerakis, et al.
Frontiers in Cell and Developmental Biology|August 8, 2022
Recent advances in targeting protein kinases and pseudokinases in cancer biologyKristina Riegel, Parthiban Vijayarangakannan, Petros Kechagioglou, et al.
Anticancer Research|March 6, 2014
Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expressionPetros Kechagioglou, Rigini M Papi, Xeni Provatopoulou, et al.
Chemical Biology & Drug Design|March 3, 2016
The Synthesis of 1,3,5-triazine Derivatives and JNJ7777120 Analogues with Histamine H4 Receptor Affinity and Their Interaction with PTEN PromoterGniewomir Latacz, Petros Kechagioglou, Rigini Papi, et al.
Iscience|June 30, 2025
CETSA-MS unveils novel targets engaged by rigosertib to promote anti-tumor activity and inflammatory responsesPetros Kechagioglou, Hajime Yurugi, Camille Dupont, et al.
Pageof 1